MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
CAS No. : 1029877-94-8
MCE 国际站:Trelagliptin succinate
产品活性:Trelagliptin (SYR-472) succinate 是一种有效的,具有口服活性 DPP-4 抑制剂,IC50 为4 nM。Trelagliptin (SYR-472) succinate 改善体内血糖控制,可用于2 型糖尿病 (T2DM) 的研究。
研究领域:Metabolic Enzyme/Protease
作用靶点:Dipeptidyl Peptidase
In Vitro: Dipeptidyl peptidase-4 (DPP-4) is one of the widely explored novel targets for type 2 diabetes mellitus (T2DM) strategy to preserve the endogenous glucagon like peptide (GLP)-1 activity by inhibiting the DPP-4 action.Trelagliptin exhibits potent inhibitory activity toward DPP-4 prepared from Caco-2 cells with an IC50 value of 5.4 nM. Trelagliptin also inhibits human, dog, and rat plasma DPP-4 activity with IC50 values of 4.2 nM, 6.2 nM, and 9.7 nM, respectively.Trelagliptin is highly selective for DPP-4 and displays IC50 values >100,000 nM corresponding to >10,000-fold selectivity over DPP-2, DPP-8, DPP-9, PEP and FAPα activities. Trelagliptin shows DPP4 selective about 4- and 12-fold more potent than alogliptin (HY-A0023) and sitagliptin (HY-13749), respectively.
In Vivo: Trelagliptin (oral gavage; 7 mg/kg; single dose) shows sustained PD effect in dogs and gives >80% inhibition of DPP-4 activity even after 24h.Trelagliptin (oral gavage; 3 mg/kg; single dose; 60 min prior to oral glucose) significantly improves the glucose tolerance capacity by decreasing the AUC0−120min of 19.3% compared with the vehicle group in ob/ob mice.Trelagliptin (oral gavage; 10 mg/kg; once a week; 8 weeks) caused significant reductions in fasting blood glucose (FBG) levels, and the average reduction during the entire treatment period is 16.8% compared to the control.It also increases insulin level and raised it by 1.7-foldin AUC0−120min in ob/ob mice.
相关产品:Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | FDA-Approved Drug Library Mini | Bioactive Compound Library Plus | Metabolism/Protease Compound Library | FDA-Approved Drug Library | Drug Repurposing Compound Library | Anti-diabetic Compound Library | Ferroptosis Compound Library | Anti-COVID-19 Compound Library | FDA Approved & Pharmacopeial Drug Library | Heterocyclic Compound Library | Highly Selective Inhibitors Library | Puromycin aminonucleoside | Sitagliptin | Talabostat mesylate | Linagliptin | Brensocatib | Saxagliptin | 1G244 | Vildagliptin | Omarigliptin | Diprotin A | Teneligliptin | Nateglinide | Alogliptin | Trelagliptin | Anagliptin | Gemigliptin tartrate | DPP-IV-IN-2 | Retagliptin phosphate | UAMC00039 dihydrochloride | DPP-IV-IN-1 | Azaleatin | DBPR108 | Dutogliptin | Evogliptin tartrate
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds